Our previous work has demonstrated that there were six DEGs identified as potential biomarkers for diagnosis of MDS, including ABAT, DAPP1, FADD, LRRFIP1, PLBD1, and SMPD3 (11). The gene discussed is DAPP1; the disease is myelodysplastic syndrome.